Abstract:AIM To prepare anti-c-Kit monoclonal antibodies and characterize their specificity of epitope recognition. METHODS cDNA encoding human c-Kit extracellular domain was constructed into a procaryotic expression vector pQE30 and the correctness of the reconstructed plasmid pQE30-KitD4-5 was verified by sequencing. The plasmid was transformed into E.coli M15 strain. Recombinant 6 x His pQE30-KitD4-5 was expressed after induction by IPTG for 4 h. Then SDS-PAGE results suggested that the products mainly formed inclusion bodies. The fusion protein was further purified with Ni-NTA-His affinity chromatography and then used to immunize BALB/c mice. The hybridomas were achieved by fusing the immunized spleen cells with the Sp2/0 myeloma cell line. The positive clones were screened by FCM with CHO-hKit cells. Hybidoma clones secreting anti-c-Kit antibodies were further subcloned and investigated for their biological activities by Western blot, rapid isotyping analysis and FCM. RESULTS Recombinant human c-Kit fusion proteins were in vitro expressed and purified to be used as immunogen. One stable hybridoma cell line, which continuously secrets specific anti-c-Kit monoclonal antibody ((SRJ1)) was established. The biological activity studies showed that the monoclonal antibody recognized the natural c-Kit expressed on the Kasumi leukemia cell line, but failed to bind to the normal human peripheral blood cells. Interestingly, this monoclonal antibody failed to recognize a subpopulation of Kasumi cells that is reactive with the commercial anti-c-Kit mAb Ab81 suggesting that the c-Kit expressed by this subpopulation contains some sequencial and/or structural aberrations that are distinguishable by mAb SRJ1. CONCLUSION With an immunization procedure using purified recombinant human c-Kit fusion proteins. a hybridoma cell line continuously and stably secreting anti-c-Kit monoclonal antibody has been established. The monoclonal antibody SRJ1 specifically recognizes human c-Kit expressed on the leukemia cells, and may provide a novel approach to analyze the possible structural variations of c-Kit expressed by different cells.

Preparation and characterization of monoclonal antibodies against human cytokeratin 19 fragment antigen 21-1

[Preparation and Characterization of Monoclonal Antibody Against Human Telomeric Repeat Binding Factor 1].

Preparation and Identification of Monoclonal Antibody Against Human Testis Development Related Gene 1

[Preparation and Characterization of the Monoclonal Antibodies Against Human CA19-9 and Establishment of a Sandwich CLIA System].

Preparation of Monoclonal Antibodies Against Hfgf-21 and Identification of Epitope

[Preparation and Characterization of the Monoclonal Antibodies Against Human CA15-3 and Establishment of a Sandwich CLIA System].

Preparation of monoclonal antibody against human tissue kallikrein and development of an ELISA kit

[Preparation of Monoclonal Antibody Against Cystatin C and Establishment of Its Immunoassay System].

[Preparation and Characterization of a Monoclonal Antibody Against Human C-Kit].

[Protein Expression, Purification of PCGF1 and Its Monoclonal Antibody Preparation and Identification].

Preparation,identification and preliminary application of monoclonal antibodies against recombinant human basic fibroblast growth factor

Preparation and characterization of monoclonal antibody against hTSC29 pep-tides

Preparation and Characterization of Monoclonal Antibody Against Human Leukocytes

Preparation and Characterization of Monoclonal Antibody to FVIII C1C2 Domain of Human

Prepartion and Identification of the Monoclonal Antibody to CTGF

[Preparation and Application of Monoclonal Antibody Against Human Myoglobin].

Preparation and Identification of Monoclonal Antibodies Against Zhangfei Fusion Protein

Ultrasensitive electrochemical detection of CYFRA 21-1 via in-situ initiated ROP signal amplification strategy

Preparation and Identification of Monoclonal Antibody Against Human Cervical Cancer Oncogene

Preparation, Characterization and Application of Anti-HCCR Monoclonal Antibody

Preparation and Identification of a Monoclonal Antibody Against Cystatin C